Associate Director for Molecular and non-traditional therapies
Timothy Doyle is an Associate Director for Molecular and non-traditional therapies. In his previous role as Operations Manager, Tim provided direct and functional supervision for all laboratories and departments. Currently, Tim is responsible for directing aspects of the Molecular lab including data generation, data review and analysis, and overseeing the design and implementation of bioinformatic pipelines. He also guides all microbiome related studies—16S rRNA and shotgun metagenomics—as well as studies involving bacteriophage testing.
Prior to joining the company in 2015, Tim was a Research Scientist at Vertex Pharmaceuticals. He was primarily responsible for the in vitro characterization of lead molecules for various antimicrobial discovery campaigns, as well as the design and execution of numerous high throughput assays. Prior to Vertex, Tim was a Senior Research Assistant at Cumbre Pharmaceuticals, where he worked on whole-cell screening and assay development for various target-based and cell-based antimicrobial drug-discovery programs. Tim has published more than 30 peer-reviewed publications and conference presentations.
Tim is an ad hoc reviewer for several journals, including mSphere and International Journal of Antimicrobial Agents.
Tim completed his B.S. from Winona State University in Winona, MN and his M.S. in Microbiology at the University of Iowa in Iowa City, IA.